Abstract：
BACKGROUND: The aim of this study is to present the current views of a diverse group of experts on the diagnosis and treatment of Cow\'s Milk Protein Allergy (CMPA) in children under 2 years of age in Mexico.
METHODS: The study, led by a scientific committee of five experts in CMPA, was divided into six phases, including a modified Delphi process. A total of 20 panelists, all of whom were pediatric specialists, participated in administering a comprehensive 38-item questionnaire. The questionnaire was divided into two blocks: Diagnosis and Treatment (20 items each).
RESULTS: Consensus was reached on all the proposed items, with an agreement rate of over 70% for each of them. As a result, a diagnostic and treatment algorithm was developed that emphasized the reduction of unnecessary diagnostic studies and encouraged breastfeeding whenever possible. In cases where breast milk is not available, appropriate use of hypoallergenic formulas was recommended. In addition, recommendations on treatment duration and gradual reintroduction of cow\'s milk protein were provided.
CONCLUSIONS: The recommendations endorsed by 20 Mexican pediatricians through this study are applicable to everyday clinical practice, thereby enhancing the diagnosis and treatment of children under 2 years of age with CMPA. This, in turn, will foster improved health outcomes and optimize the utilization of healthcare resources.
METHODS: The study, led by a scientific committee of five experts in CMPA, was divided into six phases, including a modified Delphi process. A total of 20 panelists, all of whom were pediatric specialists, participated in administering a comprehensive 38-item questionnaire. The questionnaire was divided into two blocks: Diagnosis and Treatment (20 items each).
RESULTS: Consensus was reached on all the proposed items, with an agreement rate of over 70% for each of them. As a result, a diagnostic and treatment algorithm was developed that emphasized the reduction of unnecessary diagnostic studies and encouraged breastfeeding whenever possible. In cases where breast milk is not available, appropriate use of hypoallergenic formulas was recommended. In addition, recommendations on treatment duration and gradual reintroduction of cow\'s milk protein were provided.
CONCLUSIONS: The recommendations endorsed by 20 Mexican pediatricians through this study are applicable to everyday clinical practice, thereby enhancing the diagnosis and treatment of children under 2 years of age with CMPA. This, in turn, will foster improved health outcomes and optimize the utilization of healthcare resources.
摘要：
背景：本研究的目的是介绍墨西哥2岁以下儿童牛乳蛋白过敏（CMPA）的诊断和治疗的不同专家组的最新观点。
方法：研究，由CMPA的五名专家组成的科学委员会领导，分为六个阶段，包括修改后的Delphi过程。总共有20名小组成员，他们都是儿科专家，参与管理一份全面的38项问卷。问卷分为两个部分：诊断和治疗（每个20个项目）。
结果：就所有拟议项目达成共识，他们每个人的协议率都超过70%。因此,我们开发了一种诊断和治疗算法,该算法强调减少不必要的诊断研究,并尽可能鼓励母乳喂养.在没有母乳的情况下，建议适当使用低变应原性配方.此外,提供了治疗持续时间和逐步重新引入牛乳蛋白的建议。
结论：20名墨西哥儿科医生通过本研究认可的建议适用于日常临床实践，从而提高2岁以下儿童CMPA的诊断和治疗。这个,反过来,将促进改善健康结果并优化医疗资源的利用。
方法：研究，由CMPA的五名专家组成的科学委员会领导，分为六个阶段，包括修改后的Delphi过程。总共有20名小组成员，他们都是儿科专家，参与管理一份全面的38项问卷。问卷分为两个部分：诊断和治疗（每个20个项目）。
结果：就所有拟议项目达成共识，他们每个人的协议率都超过70%。因此,我们开发了一种诊断和治疗算法,该算法强调减少不必要的诊断研究,并尽可能鼓励母乳喂养.在没有母乳的情况下，建议适当使用低变应原性配方.此外,提供了治疗持续时间和逐步重新引入牛乳蛋白的建议。
结论：20名墨西哥儿科医生通过本研究认可的建议适用于日常临床实践，从而提高2岁以下儿童CMPA的诊断和治疗。这个,反过来,将促进改善健康结果并优化医疗资源的利用。
